- Home
- AOMR vs STIM Comparison
AOMR vs STIM Comparison
Compare AOMR & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOMR
- STIM
- Stock Information
- Founded
- AOMR 2018
- STIM 2003
- Country
- AOMR United States
- STIM United States
- Employees
- AOMR N/A
- STIM N/A
- Industry
- AOMR Real Estate Investment Trusts
- STIM Medical/Dental Instruments
- Sector
- AOMR Real Estate
- STIM Health Care
- Exchange
- AOMR Nasdaq
- STIM Nasdaq
- Market Cap
- AOMR 237.8M
- STIM 232.3M
- IPO Year
- AOMR 2021
- STIM 2018
- Fundamental
- Price
- AOMR $9.66
- STIM $3.56
- Analyst Decision
- AOMR Strong Buy
- STIM Buy
- Analyst Count
- AOMR 7
- STIM 4
- Target Price
- AOMR $11.57
- STIM $6.00
- AVG Volume (30 Days)
- AOMR 82.5K
- STIM 936.2K
- Earning Date
- AOMR 08-05-2025
- STIM 08-11-2025
- Dividend Yield
- AOMR 13.31%
- STIM N/A
- EPS Growth
- AOMR N/A
- STIM N/A
- EPS
- AOMR 1.51
- STIM N/A
- Revenue
- AOMR $57,147,000.00
- STIM $89,448,000.00
- Revenue This Year
- AOMR N/A
- STIM $105.22
- Revenue Next Year
- AOMR $10.94
- STIM $11.89
- P/E Ratio
- AOMR $6.36
- STIM N/A
- Revenue Growth
- AOMR N/A
- STIM 22.16
- 52 Week Low
- AOMR $7.36
- STIM $0.52
- 52 Week High
- AOMR $12.94
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- AOMR 62.26
- STIM 46.24
- Support Level
- AOMR $9.54
- STIM $3.18
- Resistance Level
- AOMR $9.75
- STIM $3.60
- Average True Range (ATR)
- AOMR 0.15
- STIM 0.21
- MACD
- AOMR 0.05
- STIM 0.03
- Stochastic Oscillator
- AOMR 75.31
- STIM 86.00
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.